Related references
Note: Only part of the references are listed.Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial
Lieselotte Lemoine et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review
Roxan F. C. P. A. Helderman et al.
CANCERS (2019)
Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
Nina R. Sluiter et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.
Francois Quenet et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Nonparametric statistical tests for the continuous data: the basic concept and the practical use
Francis Sahngun Nahm
KOREAN JOURNAL OF ANESTHESIOLOGY (2016)
Extent of Colorectal Peritoneal Carcinomatosis: Attempt to Define a Threshold Above Which HIPEC Does Not Offer Survival Benefit: A Comparative Study
Diane Goere et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Precision medicine for cancer with next-generation functional diagnostics
Adam A. Friedman et al.
NATURE REVIEWS CANCER (2015)
Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States
K. Turaga et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Pathological Response to Neoadjuvant Chemotherapy: A New Prognosis Tool for the Curative Management of Peritoneal Colorectal Carcinomatosis
Guillaume Passot et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
Dominique Elias et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer
Jim Cassidy et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin
D Elias et al.
BRITISH JOURNAL OF SURGERY (2004)
Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients
RA Nagourney et al.
GYNECOLOGIC ONCOLOGY (2003)
TCL-1, MTCP-1 and TML-1 gene expression profile in non-leukemic clonal proliferations associated with ataxia-telangiectasia
HH Chun et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients
RA Nagourney et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
